Showing results (41-50 of 54) with videos related to
Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 12, 2012
Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trialAuayporn P Nademanee, John F DiPersio, Richard T Maziarz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2010
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myelomaPatrick J Stiff, Ivana Micallef, Auayporn P Nademanee, et al.Journal of Medicinal Chemistry|October 5, 2013
Design of substituted imidazolidinylpiperidinylbenzoic acids as chemokine receptor 5 antagonists: potent inhibitors of R5 HIV-1 replicationRenato Skerlj, Gary Bridger, Yuanxi Zhou, et al.AIDS Research and Human Retroviruses|May 18, 2019
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210Victoria A Johnson, Yoninah S Cramer, Susan L Rosenkranz, et al.Blood|July 12, 2003
Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonistW Conrad Liles, Hal E Broxmeyer, Elin Rodger, et al.Haematologica|November 16, 2016
Effect of high-dose plerixafor on CD34+ cell mobilization in healthy stem cell donors: results of a randomized crossover trialJeremy Pantin, Enkhtsetseg Purev, Xin Tian, et al.Blood|December 4, 2008
Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100Bruno Nervi, Pablo Ramirez, Michael P Rettig, et al.Cytotherapy|November 26, 2009
A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II studyStefan Fruehauf, Marlon Romano Veldwijk, Timon Seeger, et al.Supportive Cancer Therapy|July 17, 2008
Leukocytosis and Mobilization of CD34+ Hematopoietic Progenitor Cells by AMD3100, a CXCR4 AntagonistKai Hübel, W Conrad Liles, Hal E Broxmeyer, et al.British Journal of Haematology|March 1, 2011
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteersSteven J Lemery, Matthew M Hsieh, Aleah Smith, et al.Pageof 6